Glypican

Glypicans are glycosylphosphatidylinositol-anchored heparan sulfate proteoglycans on the outer plasma membrane, with six mammalian family members that regulate Wnt, Hedgehog, fibroblast growth factor, and bone morphogenetic protein signaling in context-dependent stimulatory or inhibitory modes[1]. The regulatory activity of glypicans in Wnt, Hedgehog, and BMP pathways is only partially dependent on their heparan sulfate chains[1]. Mechanistically, GPC3 can inhibit Hedgehog signaling during mammalian development by binding Hedgehog, competing with Patched, and promoting Hedgehog endocytosis and degradation; GPC3-null embryos consequently show increased Hedgehog signaling and developmental overgrowth[2]. In hepatocellular carcinoma models, GPC3 additionally functions as a Wnt coreceptor, where a protein-core Wnt3a-binding groove supports beta-catenin activation and xenograft growth[3]. For experimental inhibition, the GPC3-directed HN3-PE38 immunotoxin combines Wnt-signaling blockade with protein-synthesis inhibition and induced regression of Hep3B and HepG2 xenografts in mice[4]. Compared with GPC3, GPC5 has the opposite Hedgehog effect in rhabdomyosarcoma cells: it increases Sonic Hedgehog binding to Patched1, localizes to primary cilia, and uses glycosaminoglycan chains that are more highly sulfated than those of GPC3[5]. GPC6 also stimulates Hedgehog signaling, but in developing long bones it binds Hedgehog and Patched1, relocates to primary cilia after Hedgehog exposure, and supports skeletal growth; GPC6 loss reduces Hedgehog signaling and models omodysplasia[6].

All Product Categories